|Detection of circulating tumor DNA in early-and late-stage human malignancies|
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
|TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal|
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
|Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape|
SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ...
Cancer research 72 (4), 917-927, 2012
|In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas|
D Bell, P Chomarat, D Broyles, G Netto, GM Harb, S Lebecque, ...
The Journal of experimental medicine 190 (10), 1417-1426, 1999
|Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements|
MC Haffner, MJ Aryee, A Toubaji, DM Esopi, R Albadine, B Gurel, ...
Nature genetics 42 (8), 668-675, 2010
|LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems|
JF Grosso, CC Kelleher, TJ Harris, CH Maris, EL Hipkiss, A De Marzo, ...
The Journal of clinical investigation 117 (11), 3383-3392, 2007
|Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers|
MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber, LG Pellakuru, ...
Oncotarget 2 (8), 627, 2011
|Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes|
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
|Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity|
J Nemunaitis, C Cunningham, A Buchanan, A Blackburn, G Edelman, ...
Gene therapy 8 (10), 746-759, 2001
|Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology|
JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ...
Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019
|PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients|
TL Lotan, B Gurel, S Sutcliffe, D Esopi, W Liu, J Xu, JL Hicks, BH Park, ...
Clinical cancer research 17 (20), 6563-6573, 2011
|Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.|
AS Sarkis, DF Bajorin, VE Reuter, HW Herr, G Netto, ZF Zhang, ...
Journal of clinical oncology 13 (6), 1384-1390, 1995
|A distinctive subset of PEComas harbors TFE3 gene fusions|
P Argani, S Aulmann, PB Illei, GJ Netto, J Ro, H Cho, S Dogan, M Ladanyi, ...
The American journal of surgical pathology 34 (10), 1395-1406, 2010
|Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.|
HI Scher, A Sarkis, V Reuter, D Cohen, G Netto, D Petrylak, P Lianes, ...
Clinical Cancer Research 1 (5), 545-550, 1995
|Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer …|
AW Tong, J Nemunaitis, D Su, Y Zhang, C Cunningham, N Senzer, ...
Molecular therapy 11 (1), 160-172, 2005
|Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma|
HL Tan, A Sood, HA Rahimi, W Wang, N Gupta, J Hicks, S Mosier, ...
Clinical cancer research 20 (4), 890-903, 2014
|A model to predict severe HCV‐related disease following liver transplantation|
M Berenguer, J Crippin, R Gish, N Bass, A Bostrom, G Netto, J Alonzo, ...
Hepatology 38 (1), 34-41, 2003
|Liver transplant-associated graft-versus-host disease|
DM Smith, E Agura, G Netto, R Collins, M Levy, R Goldstein, ...
Transplantation 75 (1), 118-126, 2003
|Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients|
G Testa, JS Crippin, GJ Netto, RM Goldstein, LW Jennings, BS Brkic, ...
Liver Transplantation 6 (5), 553-561, 2000
|TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine|
I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ...
Cancer research 73 (24), 7162-7167, 2013